Superparamagnetic magnetite (Fe 3 O 4 ) nanoparticles have been widely studied for various scientific and technological applications such as magnetic storage media, 1 contrast agents for magnetic resonance imaging (MRI), 2 biolabelling and separation of biomolecules, 3 and magnetic targeted drug delivery. 4 All these applications require the magnetic nanoparticles to be chemically stable, have particle size ,20 nm with a narrow size distribution, and to be well dispersed in aqueous medium. One of the drawbacks of the above approach is that the particle size distribution is difficult to control, and the process is timeconsuming requiring further work up. On the other hand, the synthesis of magnetite nanoparticles in the presence of a surfactant can circumvent aggregation and control the size of the nanoparticles. Yaacob et al. have prepared magnetite nanoparticles at room temperature ,15 nm in diameter with a narrow size distribution of the particles which are inside vesicles based on a variety surfactants, namely cetyltrimethylammonium bromide (CTAB) and dedecylbenzenesulfonic acid (DBSA In this study we report the stabilization of superparamagnetic magnetite nanoparticles by coating them with p-sulfonato-calix[6 and 8]arenes, 1, n = 6,8, and sulfonated p-benzylcalix[4,5,6 and 8]arenes, 2, n = 4,5,6,8, Fig. 1 .{ Remarkably, stable ferrofluids are formed by a rapid and simple in situ co-precipitation from a solution of Fe(II) and Fe(III) chloride in the appropriate ratio, with aqueous ammonia, in the presence of the p-sulfonato-calixarenes and sulfonated p-benzylcalixarenes. The calixarenes not only serve as surfactants to stabilize the magnetite nanoparticles, they also functionalize the magnetite nanoparticles for potential biomedical applications, Fig. 1 www.rsc.org/chemcomm | ChemComm
